News
Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today announced the expansion of its Scientific Advisory Board to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback